• Skip to primary navigation
  • Skip to main content
  • Skip to footer

509.340.3857

info@iasismolecularsciences.com

  • LinkedIn
  • Twitter
IASIS MOLECULAR SCIENCES

IASIS MOLECULAR SCIENCES

Eco sustainable solutions for everyday life

  • About
    • Our Leadership
    • Business Advisors
  • Collaborations
  • Our Focus
  • Our Science
    • Platform No. 1
    • Platform No. 2
  • News
  • Contact Us

Our Leadership

David J. Vachon, Ph.D.

Chief Executive Officer

Dr. David Vachon is a pharmaceutics and medical device entrepreneur, with training in Science (Ph.D.) & Business (MBA).  David has spent twelve years with a large medical device company and has vast experience in areas of product development, engineering, and management (St. Jude Medical, Minimed & Medtronic). Following the acquisition of Minimed by Medtronic, he moved into a role as CTO in his first startup, Aegis Biosciences and relocated to Spokane, WA, in part due to the availability of more affordable laboratory space, a good school system and a thriving community for his family. Following an exit with Boston Scientific, he founded Iasis Molecular Sciences.

Two Patented Pre-Clinical Platforms

Our solutions are broadly bactericidal and fungicidal and can be incorporated into an array of materials for applications including medical devices and work surfaces in the clinical, consumer and industrial markets.

 

Learn More

Footer

Iasis Molecular Sciences

120 N. Pine Street, Spokane, WA 99202

509.340.3857

info@iasismolecular.com

Our Solutions

Platform No. 1

Platform No. 2

Copyright © 2023 Iasis Molecular Science. All rights reserved. Return to top